Clinical Drug Investigation

, Volume 23, Issue 4, pp 285–286 | Cite as

Fatal Cardiogenic Shock and Liver Failure Induced by Verapamil in a Thyrotoxic Patient

Case Report


Verapamil Amiodarone Thyrotoxicosis Cardiogenic Shock Flecainide 


  1. 1.
    Harrison’s Principles of Internal Medicine. 15th ed. Table 230-4: Drugs used to treat cardiac tachyarrhythmias.Google Scholar
  2. 2.
    Stajer D, Bervar M, Horvat M. Cardiogenic shock following a single therapeutic oral dose of verapamil. Int J Clin Pract 2001 Jan–Feb; 55(1): 69–70PubMedGoogle Scholar
  3. 3.
    Inoue T, Tanigawa K, Furuya H, et al. A case of thyroid crisis complicated with acute hepatic failure. Nippon Naika Gakkai Zasshi 1988 Apr; 77(4): 564–7PubMedCrossRefGoogle Scholar
  4. 4.
    Choudhary AM, Roberts I. Thyroid storm presenting with liver failure. J Clin Gastroenterol 1999 Dec; 29(4): 318–21PubMedCrossRefGoogle Scholar
  5. 5.
    Sakurai H, Kei M, Matsubara K, et al. Cardiogenic shock triggered by verapamil and atenolol: a case report of therapeutic experience with intravenous calcium. Jpn Circ J 2000 Nov; 64(11): 893–6PubMedCrossRefGoogle Scholar
  6. 6.
    Buss J, Lasserre JJ, Heene DL. Asystole and cardiogenic shock due to combined treatment with verapamil and flecainide [abstract]. Lancet 1992 Aug 29; 340(8818): 546PubMedCrossRefGoogle Scholar
  7. 7.
    Cobbe SM. Using the right drug: a treatment algorithm for atrial fibrillation. Eur Heart J 1997 May; 18Suppl C: C33–9PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2003

Authors and Affiliations

  1. 1.Department of MedicineStaten Island University HospitalStaten IslandUSA

Personalised recommendations